Related Experiment Video
Updated: Aug 15, 2026

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
Published on: January 27, 2019
Chagas disease: the peculiar relationship between parasite and host
Marie-Andrea Atsé1, Alicia Gómez-Barrio1, Cristina Fonseca-Berzal2
1Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad Complutense de Madrid (UCM), Pza. Ramón y Cajal s/n, Madrid, 28040, Spain.
Insights
The immune response influences Chagas disease (CD) progression. Understanding parasite evasion and host immunity is key to developing new therapies for this parasitic infection.
Area of Science:
- Immunology
- Parasitology
- Infectious Diseases
Background:
- Chagas disease (CD), caused by Trypanosoma cruzi, often progresses asymptomatically.
- Only a third of infected individuals develop severe chronic conditions.
- The immune system's role in CD pathogenesis is critical but not fully understood.
Purpose of the Study:
- To review the complex interplay between the host immune response and Trypanosoma cruzi.
- To explore how immune mechanisms influence Chagas disease progression and severity.
- To identify potential therapeutic targets for preventing chronic Chagas disease.
Main Methods:
- Review of existing literature on Chagas disease immunology.
- Analysis of innate and adaptive immune cell functions in CD.
- Examination of cytokine profiles (Th1/Th2) and their impact on disease outcome.
Main Results:
- Innate and adaptive immunity employ mechanisms like nitric oxide, antibodies, and cell-mediated cytotoxicity against T. cruzi.
- Parasite evasion strategies and host immune responses, including immunopathology, contribute to chronic disease development.
- The balance of pro-inflammatory and anti-inflammatory cytokines dictates disease severity.
Conclusions:
- Immune responses are crucial in determining Chagas disease progression and clinical outcomes.
- Parasite persistence and host immunopathology are key factors in the symptomatic phase of CD.
- Targeting immune mediators offers potential for novel therapeutic interventions against Chagas disease.
Abstract:
Clinical course of Chagas disease (CD), caused by the protozoan parasite Trypanosoma cruzi, usually progresses from an acute to an indeterminate phase, both characterized by the lack of specific symptoms. Only one third of patients develop life-threatening manifestations associated with the chronic infection. This fact draws attention of the scientific community to understanding the role of the immune response in the course of the disease, which is the aim of this review. On the one hand, both innate and adaptive immune cells exert antiparasitic effects by respectively releasing nitric oxide and antibodies, as well as activating perforin/granzyme or Fas/FasL pathways. Moreover, nature of secreted cytokines (i.e., pro- or anti-inflammatory) polarizes the response towards Th1 or Th2: according to the phase of CD, these profiles can be detrimental or beneficial to the host. On the other hand, the parasite has developed strategies to escape from the immune system and successfully establish the chronic disease. Also, parasite persistence, together with the immunopathology generated by the infection, seems to be important for the onset of such symptomatic phase. Since the immune response evolves through CD progression and has close relationship with the severity of the disease, study of immune mediators deserves special attention, to identify intervention points for preventing CD evolution and developing more effective therapies.
Related Concept Videos
American Trypanosomiasis
Microbial Interactions: Parasitism
Malaria
Leishmaniasis
Symbiosis
Amebiasis

